tiprankstipranks
National Health Investors (NHI)
NYSE:NHI
US Market
NHI
National Health Investors
RESEARCH TOOLSreports
Want to see NHI full AI Analyst Report?

National Health Investors (NHI) Ratios

725 Followers

National Health Investors Ratios

NHI's free cash flow for Q1 2026 was $0.31. For the 2026 fiscal year, NHI's free cash flow was decreased by $ and operating cash flow was $0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.83 2.48 0.96 1.16 3.42
Quick Ratio
 0.83 2.48 0.96 1.16 3.42
Cash Ratio
 0.06 0.16 0.06 0.07 0.17
Solvency Ratio
 0.17 0.18 0.17 0.17 0.11
Operating Cash Flow Ratio
 0.62 1.92 0.50 0.57 1.65
Short-Term Operating Cash Flow Coverage
 0.80 1.92 0.63 0.75 4.41
Net Current Asset Value
$ -1.03B$ -946.76M$ -832.28M$ -839.24M$ -834.51M
Leverage Ratios
Debt-to-Assets Ratio
 0.44 0.42 0.44 0.46 0.46
Debt-to-Equity Ratio
 0.84 0.76 0.84 0.91 0.90
Debt-to-Capital Ratio
 0.46 0.43 0.46 0.48 0.47
Long-Term Debt-to-Capital Ratio
 0.39 0.41 0.37 0.42 0.47
Financial Leverage Ratio
 1.91 1.84 1.91 1.98 1.97
Debt Service Coverage Ratio
 0.82 1.55 0.68 0.86 2.12
Interest Coverage Ratio
 4.60 3.40 3.28 3.22 3.13
Debt to Market Cap
 0.36 0.33 0.38 0.47 0.49
Interest Debt Per Share
 27.15 26.05 27.42 27.44 26.58
Net Debt to EBITDA
 4.30 4.06 4.25 4.28 6.31
Profitability Margins
Gross Profit Margin
61.26%36.70%96.67%96.40%96.48%
EBIT Margin
50.21%52.35%57.50%59.37%38.77%
EBITDA Margin
71.78%74.50%78.81%81.25%64.25%
Operating Profit Margin
48.49%51.47%54.85%55.90%47.72%
Pretax Profit Margin
36.42%37.19%40.75%42.02%23.51%
Net Profit Margin
36.76%37.56%41.17%42.41%23.87%
Continuous Operations Profit Margin
36.42%37.19%40.77%42.02%23.55%
Net Income Per EBT
100.95%100.99%101.02%100.95%101.52%
EBT Per EBIT
75.09%72.26%74.29%75.16%49.27%
Return on Assets (ROA)
5.13%5.08%5.28%5.45%2.65%
Return on Equity (ROE)
9.88%9.34%10.10%10.82%5.23%
Return on Capital Employed (ROCE)
7.84%7.29%8.36%8.26%5.54%
Return on Invested Capital (ROIC)
6.97%6.97%7.26%7.42%5.45%
Return on Tangible Assets
5.13%5.08%5.28%5.45%2.65%
Earnings Yield
4.07%3.97%4.54%5.60%2.84%
Efficiency Ratios
Receivables Turnover
 1.34 1.30 0.90 0.93 0.87
Payables Turnover
 4.12 0.00 0.30 0.34 0.38
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.14 0.14 0.13 0.13 0.11
Working Capital Turnover Ratio
 6.89 4.51 20.09 1.99 0.78
Cash Conversion Cycle
 183.14 280.21 -830.97 -693.18 -548.54
Days of Sales Outstanding
 271.64 280.21 403.36 394.37 417.47
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 88.50 0.00 1.23K 1.09K 966.01
Operating Cycle
 271.64 280.21 403.36 394.37 417.47
Cash Flow Ratios
Operating Cash Flow Per Share
 5.11 5.12 4.75 4.25 4.14
Free Cash Flow Per Share
 4.68 4.70 4.39 4.16 4.04
CapEx Per Share
 0.43 0.43 0.36 0.09 0.10
Free Cash Flow to Operating Cash Flow
 0.92 0.92 0.92 0.98 0.98
Dividend Paid and CapEx Coverage Ratio
 1.27 1.27 1.21 1.15 1.11
Capital Expenditure Coverage Ratio
 11.93 12.03 13.23 49.28 40.04
Operating Cash Flow Coverage Ratio
 0.19 0.21 0.18 0.16 0.16
Operating Cash Flow to Sales Ratio
 0.61 0.63 0.62 0.58 0.67
Free Cash Flow Yield
6.19%6.15%6.33%7.46%7.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 23.91 25.18 22.02 17.86 35.21
Price-to-Sales (P/S) Ratio
 8.82 9.46 9.07 7.58 8.40
Price-to-Book (P/B) Ratio
 2.34 2.35 2.22 1.93 1.84
Price-to-Free Cash Flow (P/FCF) Ratio
 15.71 16.25 15.79 13.41 12.94
Price-to-Operating Cash Flow Ratio
 14.35 14.90 14.60 13.14 12.62
Price-to-Earnings Growth (PEG) Ratio
 -10.86 -7.19 68.92 0.04 -0.57
Price-to-Fair Value
 2.34 2.35 2.22 1.93 1.84
Enterprise Value Multiple
 16.59 16.75 15.75 13.61 19.39
Enterprise Value
 4.90B 4.72B 4.16B 3.54B 3.47B
EV to EBITDA
 16.93 16.75 15.75 13.61 19.39
EV to Sales
 12.15 12.48 12.41 11.06 12.46
EV to Free Cash Flow
 21.65 21.45 21.62 19.57 19.18
EV to Operating Cash Flow
 19.84 19.66 19.98 19.17 18.70
Tangible Book Value Per Share
 31.71 32.85 31.59 29.36 28.81
Shareholders’ Equity Per Share
 31.35 32.46 31.17 28.90 28.37
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 >-0.01 0.00 >-0.01
Revenue Per Share
 8.34 8.08 7.64 7.37 6.21
Net Income Per Share
 3.07 3.03 3.15 3.13 1.48
Tax Burden
 1.01 1.01 1.01 1.01 1.02
Interest Burden
 0.73 0.71 0.71 0.71 0.61
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.03 0.00 0.07 0.06 0.09
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.01 0.03
Income Quality
 1.67 1.69 1.51 1.37 2.83
Currency in USD